Suven Life Sciences’ manufacturing unit at Pashmylaram here has been accepted by the US Food and Drug Administration (USFDA) for manufacture and supply or active pharmaceutical ingredients, intermediates and formulations. The unit of the Hyderabad-based company had undergone a renewal inspection by the officials of the US drug regulator recently, according to a release. So far, Suven Life had filed 29 drug master files and one abbreviated new drug application from this facility, which was a USFDA-certified facility before the present renewal as well.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.